CA3065042C - Comprime de cannabinoide a desintegration rapide - Google Patents

Comprime de cannabinoide a desintegration rapide Download PDF

Info

Publication number
CA3065042C
CA3065042C CA3065042A CA3065042A CA3065042C CA 3065042 C CA3065042 C CA 3065042C CA 3065042 A CA3065042 A CA 3065042A CA 3065042 A CA3065042 A CA 3065042A CA 3065042 C CA3065042 C CA 3065042C
Authority
CA
Canada
Prior art keywords
tablet
cannabinoid
module
composition
modular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3065042A
Other languages
English (en)
Other versions
CA3065042A1 (fr
Inventor
Heidi Ziegler Bruun
Dorthe Schackinger Boesen
Bruno Provstgaard Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordiccan AS
Original Assignee
Nordiccan AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA3065042A priority Critical patent/CA3065042C/fr
Application filed by Nordiccan AS filed Critical Nordiccan AS
Priority to JP2021561780A priority patent/JP7556882B2/ja
Priority to EP23196168.1A priority patent/EP4268815A3/fr
Priority to EP20727578.5A priority patent/EP3920891B1/fr
Priority to DK20727578.5T priority patent/DK3920891T3/da
Priority to BR112021020523A priority patent/BR112021020523A2/pt
Priority to AU2020258631A priority patent/AU2020258631B2/en
Priority to CN202080029225.3A priority patent/CN113784704A/zh
Priority to MX2021012712A priority patent/MX2021012712A/es
Priority to PL20727578.5T priority patent/PL3920891T3/pl
Priority to ES20727578T priority patent/ES2975266T3/es
Priority to FIEP20727578.5T priority patent/FI3920891T3/fi
Priority to PCT/DK2020/050102 priority patent/WO2020211915A1/fr
Publication of CA3065042A1 publication Critical patent/CA3065042A1/fr
Priority to ZA2021/07389A priority patent/ZA202107389B/en
Application granted granted Critical
Publication of CA3065042C publication Critical patent/CA3065042C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne, selon un premier aspect, un comprimé cannabinoïde à désintégration rapide, le comprimé comprenant une composition dalcool de sucre contenant une ou plusieurs particules dalcool de sucre à raison dau moins 20 % en poids du comprimé, une composition cannabinoïde contenant un ou plusieurs cannabinoïdes, et une composition de désintégration comprenant un ou plusieurs désintégrants pouvant être utilisés pour désintégrer le comprimé après un laps de temps de contact avec la salive buccale inférieur ou égal à deux minutes. Selon un second aspect, linvention concerne un comprimé modulaire, le comprimé comprenant un autre module de comprimé de composition différente.
CA3065042A 2019-04-17 2019-12-13 Comprime de cannabinoide a desintegration rapide Active CA3065042C (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
CA3065042A CA3065042C (fr) 2019-12-13 2019-12-13 Comprime de cannabinoide a desintegration rapide
ES20727578T ES2975266T3 (es) 2019-04-17 2020-04-17 Comprimidos de cannabinoides de disgregación rápida
EP20727578.5A EP3920891B1 (fr) 2019-04-17 2020-04-17 Comprimés de cannabinoïdes à désintégration rapide
DK20727578.5T DK3920891T3 (da) 2019-04-17 2020-04-17 Hurtig desintegrerende cannabinoid-tabletter
BR112021020523A BR112021020523A2 (pt) 2019-04-17 2020-04-17 Comprimidos de canabinoide de desintegração rápida
AU2020258631A AU2020258631B2 (en) 2019-04-17 2020-04-17 Fast disintegrating cannabinoid tablets
CN202080029225.3A CN113784704A (zh) 2019-04-17 2020-04-17 快速崩解大麻素片剂
MX2021012712A MX2021012712A (es) 2019-04-17 2020-04-17 Tabletas de cannabinoides de desintegracion rapida.
JP2021561780A JP7556882B2 (ja) 2019-04-17 2020-04-17 速崩壊カンナビノイド錠剤
EP23196168.1A EP4268815A3 (fr) 2019-04-17 2020-04-17 Comprimés multimodulaires de cannabinoïdes
FIEP20727578.5T FI3920891T3 (fi) 2019-04-17 2020-04-17 Nopeasti hajoavat kannabinoiditabletit
PCT/DK2020/050102 WO2020211915A1 (fr) 2019-04-17 2020-04-17 Comprimés cannabinoïdes à désintégration rapide
PL20727578.5T PL3920891T3 (pl) 2019-04-17 2020-04-17 Szybko rozpadające się tabletki kannabinoidowe
ZA2021/07389A ZA202107389B (en) 2019-04-17 2021-09-30 Fast disintegrating cannabinoid tablets

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3065042A CA3065042C (fr) 2019-12-13 2019-12-13 Comprime de cannabinoide a desintegration rapide

Publications (2)

Publication Number Publication Date
CA3065042A1 CA3065042A1 (fr) 2020-10-19
CA3065042C true CA3065042C (fr) 2021-12-07

Family

ID=72916418

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3065042A Active CA3065042C (fr) 2019-04-17 2019-12-13 Comprime de cannabinoide a desintegration rapide

Country Status (1)

Country Link
CA (1) CA3065042C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113633708B (zh) * 2021-09-27 2022-02-11 重庆希尔安药业有限公司 一种稳定的跌打七厘组合物片的制备方法

Also Published As

Publication number Publication date
CA3065042A1 (fr) 2020-10-19

Similar Documents

Publication Publication Date Title
AU2020258631B2 (en) Fast disintegrating cannabinoid tablets
US11903919B2 (en) Oral cannabinoid tablet
CA3040513C (fr) Comprime oral de cannabinoide
CA3040532C (fr) Pastille pour administration amelioree de cannabinoides
EP3920890B1 (fr) Comprimé oral de cannabinoïdes
US20230218512A1 (en) Fast Disintegrating Cannabinoid Tablets
US11241413B2 (en) Cannabinoid lozenge formulation
CA3065042C (fr) Comprime de cannabinoide a desintegration rapide
US12533367B2 (en) Self-emulsifying systems for cannabinoids
US20250261675A1 (en) Cannabinoid Lipid Premixture
KR20260034661A (ko) 칸나비노이드의 지속 방출을 위한 점착성 구강 디스크

Legal Events

Date Code Title Description
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241206

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241206